ImmunoPrecise Antibodies Ltd.

Nov 19, 2020

ImmunoPrecise and Genmab Enter into a Technology Partnership Targeting Infectious Disease

Jul 31, 2020

IPA's Human Anti-SARS-CoV-2 Therapeutic Antibodies Demonstrate Synergistic Neutralization

Jun 29, 2020

IPA Confirms Discovery of Fully Human, Potent, Neutralizing Antibodies Targeting SARS-CoV-2

Jun 11, 2020

Recombinant SARS-CoV-2 Proteins Now Available For Research From ImmunoPrecise's European Subsidiary, UPE

Mar 12, 2020

ImmunoPrecise Announces the Launch of PolyTope mAb Therapy(TM) to Tackle Coronavirus Pandemic